Review



nf κb inhibitor bay11 7082  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    MedChemExpress nf κb inhibitor bay11 7082
    Nf κb Inhibitor Bay11 7082, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 634 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pm42429058-103-8-13
    Average 99 stars, based on 634 article reviews
    nf κb inhibitor bay11 7082 - by Bioz Stars, 2026-09
    99/100 stars

    Images



    Similar Products

    99
    MedChemExpress nf κb inhibitor bay11 7082
    Nf κb Inhibitor Bay11 7082, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pm42429058-103-8-13
    Average 99 stars, based on 1 article reviews
    nf κb inhibitor bay11 7082 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitor bay11 708242
    Nf κb Inhibitor Bay11 708242, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/bio_rxiv__64898__2026__06__25__734617-55-9-29
    Average 99 stars, based on 1 article reviews
    nf κb inhibitor bay11 708242 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitor
    Nf κb Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/10__1016_slash_j__prp__2026__156525-76-5-16
    Average 99 stars, based on 1 article reviews
    nf κb inhibitor - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitor bay
    illustrates how IRAK3 inhibits <t>NF-κB,</t> thereby reducing inflammation and aging in chondrocytes. <t>BAY</t> 11-7082 is an IκBα phosphorylation and NF-κB inhibitor. The treatment concentration is 2 µM and the treatment time is 48 h. It was purchased from MedChemExpress, HY-13,453. Panel A shows the results of Western blotting, which was employed to assess the expression levels of p65 and phosphorylated p65 (p-p65) following the knockdown of IRAK3. Panel B presents the intensity and localization of p-65 as determined by immunofluorescence staining. Panels C through E display ELISA results for the detection of IL-1β, IL-6, and TNF-α expressions. Panel F shows β-galactosidase staining used to identify senescent chondrocytes. Panel G quantifies the number of positive cells. Statistical significance is indicated as follows: * p < 0.05, *** p < 0.001
    Nf κb Inhibitor Bay, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pmc13109129-46-1-14
    Average 99 stars, based on 1 article reviews
    nf κb inhibitor bay - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitors bay 11 7082
    HCV infection activated <t>the</t> <t>NF-κB</t> signaling pathway in β cells. ( A ) MIN6 cells were mock-infected or infected with 1.0 MOI of purified HCV. The presence of HCV positive strands and negative strands was detected in situ using molecular beacon probes (green). Double-stranded RNA (dsRNA) was identified via immunofluorescence assay using the J2 antibody (green). Nuclei were stained with DAPI (blue fluorescence), as shown. Scale bars, 10 μm. ( B ) MIN6 cells were transfected with the NF-κB luciferase reporter plasmid ( n = 3 biological experiments). Twenty-four hours after transfection, the NF-κB luciferase activity was quantitatively assessed at various time points following HCV infection. ( C ) Confocal microscopy images of MIN6 cells, either uninfected (first row) or infected for 24 h or 48 h at 1.0 MOI with HCV, probed with DAPI (blue) and anti-p65 (green). Scale bar, 10 μm. ( D ) Immunoblot analysis of p65 phosphorylation at Ser536, respectively, total p65 and Actin in MIN6 cells, either uninfected or infected with HCV. Values represent mean ± SD. *, p < 0.05; ***, p < 0.001
    Nf κb Inhibitors Bay 11 7082, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pmc13222928-57-1-12
    Average 99 stars, based on 1 article reviews
    nf κb inhibitors bay 11 7082 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitors bay
    HCV infection activated <t>the</t> <t>NF-κB</t> signaling pathway in β cells. ( A ) MIN6 cells were mock-infected or infected with 1.0 MOI of purified HCV. The presence of HCV positive strands and negative strands was detected in situ using molecular beacon probes (green). Double-stranded RNA (dsRNA) was identified via immunofluorescence assay using the J2 antibody (green). Nuclei were stained with DAPI (blue fluorescence), as shown. Scale bars, 10 μm. ( B ) MIN6 cells were transfected with the NF-κB luciferase reporter plasmid ( n = 3 biological experiments). Twenty-four hours after transfection, the NF-κB luciferase activity was quantitatively assessed at various time points following HCV infection. ( C ) Confocal microscopy images of MIN6 cells, either uninfected (first row) or infected for 24 h or 48 h at 1.0 MOI with HCV, probed with DAPI (blue) and anti-p65 (green). Scale bar, 10 μm. ( D ) Immunoblot analysis of p65 phosphorylation at Ser536, respectively, total p65 and Actin in MIN6 cells, either uninfected or infected with HCV. Values represent mean ± SD. *, p < 0.05; ***, p < 0.001
    Nf κb Inhibitors Bay, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pm41999495-78-1-12
    Average 99 stars, based on 1 article reviews
    nf κb inhibitors bay - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitor bay 11 7082
    HCV infection activated <t>the</t> <t>NF-κB</t> signaling pathway in β cells. ( A ) MIN6 cells were mock-infected or infected with 1.0 MOI of purified HCV. The presence of HCV positive strands and negative strands was detected in situ using molecular beacon probes (green). Double-stranded RNA (dsRNA) was identified via immunofluorescence assay using the J2 antibody (green). Nuclei were stained with DAPI (blue fluorescence), as shown. Scale bars, 10 μm. ( B ) MIN6 cells were transfected with the NF-κB luciferase reporter plasmid ( n = 3 biological experiments). Twenty-four hours after transfection, the NF-κB luciferase activity was quantitatively assessed at various time points following HCV infection. ( C ) Confocal microscopy images of MIN6 cells, either uninfected (first row) or infected for 24 h or 48 h at 1.0 MOI with HCV, probed with DAPI (blue) and anti-p65 (green). Scale bar, 10 μm. ( D ) Immunoblot analysis of p65 phosphorylation at Ser536, respectively, total p65 and Actin in MIN6 cells, either uninfected or infected with HCV. Values represent mean ± SD. *, p < 0.05; ***, p < 0.001
    Nf κb Inhibitor Bay 11 7082, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pm41925099-102-17-24
    Average 99 stars, based on 1 article reviews
    nf κb inhibitor bay 11 7082 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress nf κb inhibitor hy 13453
    HCV infection activated <t>the</t> <t>NF-κB</t> signaling pathway in β cells. ( A ) MIN6 cells were mock-infected or infected with 1.0 MOI of purified HCV. The presence of HCV positive strands and negative strands was detected in situ using molecular beacon probes (green). Double-stranded RNA (dsRNA) was identified via immunofluorescence assay using the J2 antibody (green). Nuclei were stained with DAPI (blue fluorescence), as shown. Scale bars, 10 μm. ( B ) MIN6 cells were transfected with the NF-κB luciferase reporter plasmid ( n = 3 biological experiments). Twenty-four hours after transfection, the NF-κB luciferase activity was quantitatively assessed at various time points following HCV infection. ( C ) Confocal microscopy images of MIN6 cells, either uninfected (first row) or infected for 24 h or 48 h at 1.0 MOI with HCV, probed with DAPI (blue) and anti-p65 (green). Scale bar, 10 μm. ( D ) Immunoblot analysis of p65 phosphorylation at Ser536, respectively, total p65 and Actin in MIN6 cells, either uninfected or infected with HCV. Values represent mean ± SD. *, p < 0.05; ***, p < 0.001
    Nf κb Inhibitor Hy 13453, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nf+%CE%BAb+inhibitor+bay/BAY+11-7082/pm41887487-44-27-30
    Average 99 stars, based on 1 article reviews
    nf κb inhibitor hy 13453 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    illustrates how IRAK3 inhibits NF-κB, thereby reducing inflammation and aging in chondrocytes. BAY 11-7082 is an IκBα phosphorylation and NF-κB inhibitor. The treatment concentration is 2 µM and the treatment time is 48 h. It was purchased from MedChemExpress, HY-13,453. Panel A shows the results of Western blotting, which was employed to assess the expression levels of p65 and phosphorylated p65 (p-p65) following the knockdown of IRAK3. Panel B presents the intensity and localization of p-65 as determined by immunofluorescence staining. Panels C through E display ELISA results for the detection of IL-1β, IL-6, and TNF-α expressions. Panel F shows β-galactosidase staining used to identify senescent chondrocytes. Panel G quantifies the number of positive cells. Statistical significance is indicated as follows: * p < 0.05, *** p < 0.001

    Journal: Journal of Molecular Histology

    Article Title: Interleukin-1 Receptor-Associated Kinase 3 Attenuates Chondrocyte Senescence and Osteoarthritis via Inhibition of the TLR7/9–NF-κB Axis

    doi: 10.1007/s10735-026-10804-4

    Figure Lengend Snippet: illustrates how IRAK3 inhibits NF-κB, thereby reducing inflammation and aging in chondrocytes. BAY 11-7082 is an IκBα phosphorylation and NF-κB inhibitor. The treatment concentration is 2 µM and the treatment time is 48 h. It was purchased from MedChemExpress, HY-13,453. Panel A shows the results of Western blotting, which was employed to assess the expression levels of p65 and phosphorylated p65 (p-p65) following the knockdown of IRAK3. Panel B presents the intensity and localization of p-65 as determined by immunofluorescence staining. Panels C through E display ELISA results for the detection of IL-1β, IL-6, and TNF-α expressions. Panel F shows β-galactosidase staining used to identify senescent chondrocytes. Panel G quantifies the number of positive cells. Statistical significance is indicated as follows: * p < 0.05, *** p < 0.001

    Article Snippet: The NF-κB inhibitor BAY 11-7082, along with TLR7/9 agonists and inhibitors, were procured from MedChemExpress.

    Techniques: Phospho-proteomics, Concentration Assay, Western Blot, Expressing, Knockdown, Immunofluorescence, Staining, Enzyme-linked Immunosorbent Assay

    HCV infection activated the NF-κB signaling pathway in β cells. ( A ) MIN6 cells were mock-infected or infected with 1.0 MOI of purified HCV. The presence of HCV positive strands and negative strands was detected in situ using molecular beacon probes (green). Double-stranded RNA (dsRNA) was identified via immunofluorescence assay using the J2 antibody (green). Nuclei were stained with DAPI (blue fluorescence), as shown. Scale bars, 10 μm. ( B ) MIN6 cells were transfected with the NF-κB luciferase reporter plasmid ( n = 3 biological experiments). Twenty-four hours after transfection, the NF-κB luciferase activity was quantitatively assessed at various time points following HCV infection. ( C ) Confocal microscopy images of MIN6 cells, either uninfected (first row) or infected for 24 h or 48 h at 1.0 MOI with HCV, probed with DAPI (blue) and anti-p65 (green). Scale bar, 10 μm. ( D ) Immunoblot analysis of p65 phosphorylation at Ser536, respectively, total p65 and Actin in MIN6 cells, either uninfected or infected with HCV. Values represent mean ± SD. *, p < 0.05; ***, p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: HCV infection induces dysregulation of glucose-stimulated insulin secretion via the TLR3/TRIF/NF-κB-iNOS-NO axis: Implications for prediabetes in HCV patients

    doi: 10.1007/s00018-025-06072-2

    Figure Lengend Snippet: HCV infection activated the NF-κB signaling pathway in β cells. ( A ) MIN6 cells were mock-infected or infected with 1.0 MOI of purified HCV. The presence of HCV positive strands and negative strands was detected in situ using molecular beacon probes (green). Double-stranded RNA (dsRNA) was identified via immunofluorescence assay using the J2 antibody (green). Nuclei were stained with DAPI (blue fluorescence), as shown. Scale bars, 10 μm. ( B ) MIN6 cells were transfected with the NF-κB luciferase reporter plasmid ( n = 3 biological experiments). Twenty-four hours after transfection, the NF-κB luciferase activity was quantitatively assessed at various time points following HCV infection. ( C ) Confocal microscopy images of MIN6 cells, either uninfected (first row) or infected for 24 h or 48 h at 1.0 MOI with HCV, probed with DAPI (blue) and anti-p65 (green). Scale bar, 10 μm. ( D ) Immunoblot analysis of p65 phosphorylation at Ser536, respectively, total p65 and Actin in MIN6 cells, either uninfected or infected with HCV. Values represent mean ± SD. *, p < 0.05; ***, p < 0.001

    Article Snippet: The NF-κB inhibitors BAY 11–7082 and Pyrrolidinedithiocarbamate ammonium (PDTC) were obtained from MCE (MedChemExpress, USA).

    Techniques: Infection, Purification, In Situ, Immunofluorescence, Staining, Fluorescence, Transfection, Luciferase, Plasmid Preparation, Activity Assay, Confocal Microscopy, Western Blot, Phospho-proteomics

    HCV stimulated the expression of iNOS via TLR3/Trif/NF-κB pathway. ( A ) DAF-FM DA measurements were detected following HCV infection in the presence of NF-κB inhibitor, BAY 11–7082 (100 μM). The NOS inhibitors L-NMMA (total NOS inhibitor, 100 μM) and 1400 W (iNOS inhibitor, 100 μM) were used as the positive control ( n = 6 biological experiments). ( B ) Immunoblot analysis of phosphorylated ( p -) or total p65, iNOS or Actin (loading control throughout) in MIN6 cells. The cells were infected with HCV for 12 h and subsequently treated with BAY or L-NMMA or left untreated. ( C ) Islets were isolated from C57BL/6N mice or from Tlr3 −/− , Tlr4 −/− , Tlr7 −/− , Tlr7/Tlr9 −/− or Trif/Myd88 . −/− knockout single or double knockout mice and then infected with HCV for 24 h. Insulin secretion were measured under low glucose conditions (3.3 mM) in the presence of BAY (100 μM) or PDTC (100 μM) ( n = 3 biological experiments). ( D ) Immunoblot analysis was conducted to evaluate the levels of p-p65 or total p65, as well as iNOS or Actin, in islets isolated from the indicated mice. ( E ) Insulin secretion was measured in islets derived from the indicated mice following 24-h HCV infection ( n = 3 biological experiments). Values represent mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: HCV infection induces dysregulation of glucose-stimulated insulin secretion via the TLR3/TRIF/NF-κB-iNOS-NO axis: Implications for prediabetes in HCV patients

    doi: 10.1007/s00018-025-06072-2

    Figure Lengend Snippet: HCV stimulated the expression of iNOS via TLR3/Trif/NF-κB pathway. ( A ) DAF-FM DA measurements were detected following HCV infection in the presence of NF-κB inhibitor, BAY 11–7082 (100 μM). The NOS inhibitors L-NMMA (total NOS inhibitor, 100 μM) and 1400 W (iNOS inhibitor, 100 μM) were used as the positive control ( n = 6 biological experiments). ( B ) Immunoblot analysis of phosphorylated ( p -) or total p65, iNOS or Actin (loading control throughout) in MIN6 cells. The cells were infected with HCV for 12 h and subsequently treated with BAY or L-NMMA or left untreated. ( C ) Islets were isolated from C57BL/6N mice or from Tlr3 −/− , Tlr4 −/− , Tlr7 −/− , Tlr7/Tlr9 −/− or Trif/Myd88 . −/− knockout single or double knockout mice and then infected with HCV for 24 h. Insulin secretion were measured under low glucose conditions (3.3 mM) in the presence of BAY (100 μM) or PDTC (100 μM) ( n = 3 biological experiments). ( D ) Immunoblot analysis was conducted to evaluate the levels of p-p65 or total p65, as well as iNOS or Actin, in islets isolated from the indicated mice. ( E ) Insulin secretion was measured in islets derived from the indicated mice following 24-h HCV infection ( n = 3 biological experiments). Values represent mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.001

    Article Snippet: The NF-κB inhibitors BAY 11–7082 and Pyrrolidinedithiocarbamate ammonium (PDTC) were obtained from MCE (MedChemExpress, USA).

    Techniques: Expressing, Infection, Positive Control, Western Blot, Control, Isolation, Knock-Out, Double Knockout, Derivative Assay